WX [WuXi PharmaTech (Cayman)] SC 13D/A: (Original Filing)

[EXECUTION COPY VOTING AGREEMENT “Acquiror” Shareholder Shareholders AGREEMENT, dated as of April 26, 2010 between Charles River Laboratories International, Inc., a Delaware corporation ( Acquisition Agreemen Company Shares ADSs provided WHEREAS, in order to induce Acquiror to enter into an Agreement and Plan of Arrangement, dated as of the date hereof (the “ NOW, THEREFORE, the parties hereto agree as] []

By | 2016-04-02T20:12:36+00:00 April 27th, 2010|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments

WX [WuXi PharmaTech (Cayman)] SC 13D/A: EXECUTION COPY VOTING AGREEMENT “Acquiror” Shareholder Shareholders AGREEMENT,

[EXECUTION COPY VOTING AGREEMENT “Acquiror” Shareholder Shareholders AGREEMENT, dated as of April 26, 2010 between Charles River Laboratories International, Inc., a Delaware corporation ( Acquisition Agreemen Company Shares ADSs provided WHEREAS, in order to induce Acquiror to enter into an Agreement and Plan of Arrangement, dated as of the date hereof (the “ NOW, THEREFORE, the parties hereto agree as] []

By | 2016-04-02T20:13:47+00:00 April 27th, 2010|Categories: Chinese Stocks, Webplus ver, WX|Tags: , , , , , |0 Comments

WX [WuXi PharmaTech (Cayman)] 20-F: (Original Filing)

[TABLE OF CONTENTS Page INTRODUCTION 1 2 PART I. ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THE COMPANY 28 ITEM 4A. UNRESOLVED STAFF COMMENTS 47 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 47 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND] [LIST OF SUBSIDIARIES • • WX (BVI) Limited, incorporated in the British Virgin Islands. • WuXi AppTec (BVI) Inc., incorporated in the British Virgin Islands. • • Kaipara Enterprises Limited, incorporated in Cyprus. • Klivia Investments Sp. zo.o., incorporated in Poland. • Klivia Investments Sp. zo.o. Luxembourg Branch, incorporated in Luxembourg. • WuXi AppTec Co., Ltd., incorporated in the People’s] [Certification by the Chief Executive Officer I, Ge Li, certify that: 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered] [Certification by the Chief Financial Officer I, Edward Hu, certify that: 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered] [Section 906 of the Sarbanes-Oxley Act of 2002 Ge Li Chief Executive Officer] [Certification by the Chief Financial Officer Edward Hu Acting Chief Financial Officer] [April 23, 2010 WuXi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131 People’s Republic of China RE: WUXI PHARMATECH (CAYMAN) INC. Dear Sirs/Madams, Company We have acted as legal advisors as to the laws of the People’s Republic of China to WuXi PharmaTech (Cayman) Inc., an exempted limited liability company incorporated in the Cayman Islands] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-146730 on Form S-8 and in Registration Statement No. 333-161757 on Form F-3 of our reports dated April 23, 2010, relating to the consolidated financial statements and financial statement schedule of WuXi PharmaTech (Cayman) Inc, and the effectiveness WuXi PharmaTech (Cayman) Inc.’s]

By | 2016-04-02T20:17:43+00:00 April 23rd, 2010|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments

WX [WuXi PharmaTech (Cayman)] SC 13G/A: (Original Filing)

[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 85,878,400 Item 6: 0 Item 7: 91,966,328 Item 8: 0 Item 9: 91,966,328 Item 11: 16.768% Item 12: HC Cusip #929352920 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 91,966,328 Item 8: 0 Item 9: 91,966,328 Item 11: 16.768%]

By | 2016-04-02T20:23:02+00:00 February 16th, 2010|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments

WX [WuXi PharmaTech (Cayman)] SC 13G/A: Item 1: Reporting Person – FMR LLC Item

[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 85,878,400 Item 6: 0 Item 7: 91,966,328 Item 8: 0 Item 9: 91,966,328 Item 11: 16.768% Item 12: HC Cusip #929352920 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 91,966,328 Item 8: 0 Item 9: 91,966,328 Item 11: 16.768%]

By | 2016-04-02T20:23:53+00:00 February 16th, 2010|Categories: Chinese Stocks, Webplus ver, WX|Tags: , , , , , |0 Comments
Skip to toolbar